...

首页> 外文期刊>Annals of allergy, asthma, and immunology >RITUXIMAB ASSOCIATED ANTIBODY DYSFUNCTION IN B CELL NON-HODGKIN'S LYMPHOMA

【24h】

RITUXIMAB ASSOCIATED ANTIBODY DYSFUNCTION IN B CELL NON-HODGKIN'S LYMPHOMA

机译：RITUXIMAB相关抗体功能障碍在B细胞非霍奇金淋巴瘤中

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of allergy, asthma, and immunology》 |2018年第1期|共1页
作者
Mustafa S.; Ramsey A.; Jamshed S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. RITUXIMAB ASSOCIATED ANTIBODY DYSFUNCTION IN B CELL NON-HODGKIN'S LYMPHOMA [J] . S. Mustafa, A. Ramsey, S. Jamshed Annals of allergy, asthma, and immunology . 2018,第5期

机译：RITUXIMAB相关抗体功能障碍在B细胞非霍奇金淋巴瘤中
2. A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study [J] . Matsumoto Kimihiro, Takayama Nobuyuki, Aisa Yoshinobu, International journal of hematology . 2015,第6期

机译：苯达莫司汀加利妥昔单抗在日本复发或难治的惰性B细胞非霍奇金淋巴瘤和套细胞淋巴瘤的先前接受利妥昔单抗治疗的II期临床研究：BRB研究
3. A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab [J] . Sawas Ahmed, Farber Charles M., Schreeder Marshall T., British Journal of Haematology . 2017,第2期

机译：Ublituximab的1/2试验，一种新型的抗CD20单克隆抗体，B细胞非霍奇金淋巴瘤或先前暴露于Rituximab的慢性淋巴细胞白血病
4. Development of Single Domain Antibodies for Diagnosis and Treatment of Naturally Occurring Canine Lymphoma: An Animal Model for Human Non-Hodgkin Lymphoma [C] . Joana Dias, Solange Gil, Belmira Carrapico, PEGS . 2015

机译：天然犬淋巴瘤诊断和治疗单结构域抗体的发展：人非霍奇金淋巴瘤的动物模型
5. Regulation of CD20 in rituximab-resistant cell lines (RRCL) and B-cell non-Hodgkin's lymphoma (B-NHL) [D] . Tsai, Ping-Chiao 2012

机译：CD20在利妥昔单抗耐药细胞系（RRCL）和B细胞非霍奇金淋巴瘤（B-NHL）中的调节
6. Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [O] . Ranjana H. Advani, Daniel Lebovic, Andy Chen, -1

机译：复发/难治性B细胞非霍奇金淋巴瘤患者抗CD22抗体-药物缀合吡妥珠单抗Vedotin联合利妥昔单抗治疗的I期研究
7. Faculty Opinions recommendation of A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab. [O] . Varsha Gandhi, Prithviraj Bose 2017

机译：教师意见建议Ublituximab的一期ublituximab试验，一种新型抗CD20单克隆抗体，B细胞非霍奇金淋巴瘤或先前暴露于利妥昔单抗的慢性淋巴细胞白血病。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号